Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases 04 Jan 2024 Health
Novo Nordisk and University of Maastricht announce international research collaboration for cardiovascular diseases 25 Oct 2023 News
Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases 26 Sep 2023 News
Aspect Biosystems and Novo Nordisk enter partnership to develop bioprinted tissue therapeutics 13 Apr 2023 Health
Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders 01 Sep 2022 News
Novo Nordisk and Flagship Pioneering announce a strategic collaboration to create a portfolio of transformational medicines 10 May 2022 News
KU Leuven spin-out enters licence agreement with Novo Nordisk KU Leuven spin-out enters licence agreement with Novo Nordisk reMYND enters into license agreement to further develop novel treatments improving beta-cell health and insulin signalling with Novo Nordisk 14 Dec 2017 Health